F. Celik Et Al. , "Interleukin 18, soluble cluster of differentiation 40, platelet factor 4 variant 1, and neutrophil gelatinase-associated lipocalin can be used as biomarkers to aid activity and diagnosis in ocular Behçet’s disease," International Ophthalmology , vol.42, no.11, pp.3321-3331, 2022
Celik, F. Et Al. 2022. Interleukin 18, soluble cluster of differentiation 40, platelet factor 4 variant 1, and neutrophil gelatinase-associated lipocalin can be used as biomarkers to aid activity and diagnosis in ocular Behçet’s disease. International Ophthalmology , vol.42, no.11 , 3321-3331.
Celik, F., Coteli, E., Gul, F. C., Ozsoy, E., Kobat, S. G., Karagoz, Z. K., ... Aydin, S.(2022). Interleukin 18, soluble cluster of differentiation 40, platelet factor 4 variant 1, and neutrophil gelatinase-associated lipocalin can be used as biomarkers to aid activity and diagnosis in ocular Behçet’s disease. International Ophthalmology , vol.42, no.11, 3321-3331.
Celik, Fatih Et Al. "Interleukin 18, soluble cluster of differentiation 40, platelet factor 4 variant 1, and neutrophil gelatinase-associated lipocalin can be used as biomarkers to aid activity and diagnosis in ocular Behçet’s disease," International Ophthalmology , vol.42, no.11, 3321-3331, 2022
Celik, Fatih Et Al. "Interleukin 18, soluble cluster of differentiation 40, platelet factor 4 variant 1, and neutrophil gelatinase-associated lipocalin can be used as biomarkers to aid activity and diagnosis in ocular Behçet’s disease." International Ophthalmology , vol.42, no.11, pp.3321-3331, 2022
Celik, F. Et Al. (2022) . "Interleukin 18, soluble cluster of differentiation 40, platelet factor 4 variant 1, and neutrophil gelatinase-associated lipocalin can be used as biomarkers to aid activity and diagnosis in ocular Behçet’s disease." International Ophthalmology , vol.42, no.11, pp.3321-3331.
@article{article, author={Fatih Celik Et Al. }, title={Interleukin 18, soluble cluster of differentiation 40, platelet factor 4 variant 1, and neutrophil gelatinase-associated lipocalin can be used as biomarkers to aid activity and diagnosis in ocular Behçet’s disease}, journal={International Ophthalmology}, year=2022, pages={3321-3331} }